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Abstract 
 
Background: To gauge the clinical spectrum of dengue 
fever in northern Pakistan and to assess its hepatic 
implications 
Methods: This prospective study was conducted at 
Rawalpindi General Hospital (now BBH), Rawalpindi 
from 1st Oct 2006 to 31st Dec 2008. It included all 264 
patients suffering from dengue fever who presented 
during this period. Dengue infection was suspected if two 
or more of the following features in addition to fever were 
present: headache, retro-orbital pain, myalgias/arthralgias, 
scarlet/maculopapular rash, vomiting/epigastric pain and 
haemorrhagic manifestations. Blood samples were sent for 
dengue virus IgM. A blood complete picture, liver 
function tests, serum urea and creatinine, and urine R/E 
were also obtained. Specific evidence of liver involvement 
was also sought on examination. 
Results: The 264 patients comprised of 146 males and 
118 females. Age of patients ranged from 14 to 80 years. 220 
patients were seen in the last three months of 2006, the 
time of the dengue epidemic. Fever and myalgias were 
present in all patients. Vomiting was seen in 223 (85%) and 
abdominal pain in 163 (62%) patients. A skin rash was 
present in 148 (56%) while 56 (21%) complained of joint 
pains and 53 (20%) of retro-orbital pain. 26 (10%) patients 
had a bleeding disposition and jaundice was noted in 6 
(2%). 
Leukopenia and thrombocytopenia were present in all 
patients, while 254 (96%) had proteinuria. ALT was 
elevated in 163 (62%) and AST was raised in 135 (51%) 
patients. 
Conclusion: The liver is affected in a large number of 
cases of dengue fever. Liver function tests are useful to 
evaluate the degree of liver damage and markers such as 
AST and ALT may be used as parameters to assess 
severity. 
. 
Introduction   
Dengue fever (DF) is an acute infectious 
disease of antiquity. It is probably the most important 
arthropod-borne viral disease in terms of human 
morbidity and mortality, with several million 
infections occurring annually for which no effective 
therapy exists. The clinical spectrum ranges from a 
self-limiting infection to more severe forms like 
dengue haemorrhagic fever (DHF) or dengue shock 
syndrome (DSS) with a mortality rate of up to 40 
percent.1 
In the past twenty years, dengue has re-
emerged with an expanded geographic distribution of 
both the virus and the mosquito vector, increased 
epidemic activity, the development of hyper 
endemicity (co-circulation of multiple serotypes) and 
the emergence of dengue haemorrhagic fever in new 
geographic regions. All four dengue serotypes are now 
endemic around the globe. The reasons for this 
resurgence and emergence of dengue haemorrhagic 
fever are complex and not fully understood. However, 
demographic, societal and public health infrastructure 
changes in the past 30 years seem to have contributed 
greatly.2, 3  
Hepatic dysfunction is common in dengue 
infection and is attributed to a direct viral effect on 
liver cells or as a consequence of dysregulated host 
immune responses against the virus.4, 5 However liver 
function abnormalities and associated pathologic 
findings are not always mentioned in dengue 
literature. Liver involvement may be characterised by 
pain in the right hypochondrium, hepatomegaly, 
varying degrees of jaundice and an increase in liver 
markers, mainly ALT and AST as found in acute 
hepatitis caused by A,B,C,D and E viruses. Pathologic 
findings include centrilobular necrosis, fatty change, 
kupffer cell hyperplasia, acidophilic bodies and 
monocyte infiltration.6, 7 
In 2006, dengue fever reached epidemic 
proportions in Pakistan’s largest city Karachi, and with 
mass northward movement of the working class to 
their homes for the Eid vacations, spread all over the 
country.8 A large number of patients were also 
reported from Rawalpindi with Rawalpindi General 
Hospital bearing the brunt of the influx in the city. 
From October to December 2006 alone, 220 cases of DF 
and DHF were managed by us.  
The purpose of this study was identify the 
presenting features and variance in clinical 
presentation of dengue fever, as well as to gauge the 
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spectrum of liver involvement in patients afflicted by 
the disease.  
Patients and Methods 
 
This Prospective Study was conducted at Rawalpindi 
General Hospital (now Benazir Bhutto Hospital), a 
tertiary care referral center and teaching hospital of 
Rawalpindi Medical College, Rawalpindi. It included 
264 patients who presented with dengue fever from 
1st October 2006 to 31st December 2008. All were more 
than 14 years of age and presented with an acute 
febrile illness. Dengue fever was suspected if two or 
more of the following features in addition to fever 
were present: headache ,retro –orbital pain, myalgias, 
arthralgias, scarlet  /maculopapular rash, vomiting 
/epigastric pain and hemorrhagic manifestations. 
Laboratory investigation criteria were also laid down. 
Patients with acute febrile illness having leucopenia 
(TLC < 4.0X109/L) and/or thrombocytopaenia 
(Platelets < 150x109/L) and deranged transaminases 
were also worked up for dengue fever. For a definite 
diagnosis, blood samples were sent to National 
Institute of Health, Islamabad where Dengue virus 
IgM was performed by standardized ELISA method 
(Serum ELISA IgM Kit: sensitivity 86% specificity 
100%). To avoid false negative results, it was ensured 
that patients had a history of fever of at least one week 
duration before collecting the blood samples for the 
test. Within two months of commencement of the 
study, this kit became available at our hospital and 
blood samples were also tested here.  
                     A blood complete picture, liver function 
tests, serum urea and creatinine, prothrombin time 
and urine R/E were also obtained. Considering the 
overlapping signs and symptoms and endemic nature 
of typhoid fever and malaria in our region, all patients 
also underwent appropriate smear or serological tests 
for these diseases (Widal /Typhidot and malarial 
parasite smears for three consecutive days). Once a 
definite diagnosis of Dengue fever was established, 
only symptomatic treatment was advised and the 
patients monitored for DHF and DSS, using current 
guidelines of WHO and Pan American Health 
Organization as under.9 
                      Dengue haemorrhagic fever was 
diagnosed when the patient fulfilled the following 
clinical criteria: Fever, any haemorrhagic 
manifestation, thrombocytopaenia (platelet count 
100,000/ml or less) and objective evidence of increased 
capillary permeability. The latter was documented by 
either haemoconcentration (an increase in haematocrit 
of 20% or greater from average, or decrease by an 
equivalent amount from base line after intravenous 
fluid therapy), pleural or abdominal effusion (by 
radiography /ultrasonography) or hypoalbuminemia 
/ hypoproteinemia. When the only haemorrhagic 
manifestation was provoked (by a tourniquet test) the 
patient was categorised as a case of Grade I Dengue 
Haemorrhagic fever. A spontaneous hemorrhage, even 
if mild, indicated Grade II illness. Grade III and IV 
DHF (incipient and frank circulatory failure 
respectively) were taken to represent dengue shock 
syndrome.  
All clinical presentations and laboratory 
findings were recorded in the study Specific evidence 
of liver involvement was also sought on examination. 
Descriptive analysis was performed using SPSS 10.0 
programmer.   
 
Results 
 
The 264 patients studied comprised 146 males 
and 118 females (male to female ratio 1.2:1). Age of 
patients ranged from 14 to 80 years. The mean age was 
30.4 years. The highest incidence occurred in those 
aged between 14 to 35 years with 177 (67%) patients 
figuring in this age range. 
  
Table 1: Clinical features in patients (n=264) 
Clinical Features Patients Percentage 
Fever 264 100% 
Myalgias 264 100% 
Vomiting 223 85% 
Abdominal pain 163 62% 
Skin rash 148 56% 
Joint pains 56 21% 
Retro-orbital pain 53 20% 
Headache 42 16% 
Bleeding 
manifestation 
26 10% 
Sore throat 13 5% 
Dry cough 13 5% 
Jaundice 6 2% 
Productive cough 2 0.8% 
The most common clinical features were fever 
and myalgias which were present in all 264 patients 
(Table 1). Fever was high grade, ranging from 101 to 
105 F, intermittent and accompanied by chills & rigors. 
Vomiting was seen in 223(85%), abdominal pain in 
163(62%) and a skin rash in 148(56%) patients. 56(21%) 
patients complained of joint pains, 53(20%) of retro-
orbital pain while 42(16%) had severe headache. 
26(10%) patients had a bleeding disposition in the 
form of epistaxis, haematemesis or melena. Jaundice 
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was noted in 6(2%). Other symptoms included sore 
throat and cough. 
Laboratory findings revealed leukopenia and 
thrombocytopenia in all patients (table 2). TLC ranged 
from 1.5 TO 3.3 X 109/L. PCV ranged from 21.5 to 62. 
Proteinuria was detected in 254(96%) patients. A 
raised ALT was seen in 163(62%) and raised AST in 
135(51%) patients. Bilirubin was elevated in 8(3%) 
patients. 
Of the 264 patients 259(98%) subsequently 
recovered. Those with DHF and DSS were managed 
with platelet concentrates and blood transfusions. All 
five (2.7%) mortalities had DHF or DSS and occurred 
in the period 2007 to 2008. All 220 patients seen in the 
last 3 months of 2006 recovered and were eventually 
discharged from hospital. This included twenty two 
patients with DHF. 
 
Table 2: Laboratory findings (n=264) 
Lab findings Patients Percentage 
Leukopenia 264 100% 
Thrombocytopenia 264 100% 
Proteinuria 254 96% 
Elevated ALT 163 62% 
Elevated AST 135 51% 
Elevated Bilirubin 8 3% 
 
Discussion 
 
In 1994, dengue haemorrhagic fever was first 
reported in Pakistan from Karachi.10 Sporadic cases 
continued to surface from Haripur in 2003 and Attock 
in 2004 until the 2006 epidemic which also originated 
from Karachi and spread north. The emergence and 
re-emergence of DF and DHF in northern Pakistan 
seems related to the increase in density and 
geographic distribution of the vector and increase in 
the rate and geographic range of virus transmission. 
Illiteracy, poverty, sub-standard living conditions plus 
deterioration of health systems and mosquito control 
programmes have all been blamed. The increase in air 
travel allows the movement of different serotypes, 
strains and genotypes of the virus from one region to 
another. Individuals in the viremic phase are able to 
introduce a new virus into a susceptible population. 
WHO reported that a temperature rise of 1 to 
2° C could result in an increase of the risk population 
by several hundred million, with 20,000 to 30,000 more 
fatal cases annually world-wide.9 The implications of 
global warming are glaringly obvious. Most of our 
patients, who reported in the autumn of 2006, came 
from relatively cleaner, greener, suburban areas of the 
city and beyond. However as winter set in, the 
numbers declined but now the majority presented 
from congested and warmer areas of Rawalpindi. 
The involvement of liver in the pathogenesis 
of dengue virus has been indicated by clinical signs of 
hepatomegaly, abnormal liver function, pathological 
findings and detection of viral antigens.11-14 A transient 
liver transaminase elevation is commonly found. 
Predictive factors for liver damage have been 
identified which include DHF, secondary infection, 
thrombocytopenia, high haematocrit, female sex and 
children.15, 16 Wong and Shen found elevated levels of 
AST in 90.6% of their 127 patients and raised ALT 
levels in 71.1%, while both ALT and AST were 
increased in 70.9%. Low levels of globulin were 
observed in 14.4% and low albumin levels in 16.5% of 
their patients.15 
Dengue virus-induced damage to hepatocytes, 
hypoxia, shock or associated liver disease have all 
been postulated to be the pathogenic mechanisms for 
elevated transaminases.16 Daniel et al17 noted 
hepatomegaly in 17.6% of their 250 patients. Bilirubin 
was above 2 mg% in 9.7% and AST was raised in 84%. 
No mortality was observed in those with a normal 
AST while it was 4.1% in patients with a raised AST. 
This suggests a worse outcome in patients with a 
raised AST. Ascites was detected by ultrasound in 12% 
of their patients. 62.4% had abdominal pain, a 
symptom which is predominately seen in early leak 
phase and is attributed to hepatomegaly and serosal 
inflammation.17 
Sharma et al noted abdominal pain in 38%and 
hepatomegaly in 12% of their series. However 
transaminases were elevated in 90% of patients.18 
Elevated transaminases were also noted in 66% of 80 
patients with DF in Jeddah, Saudi Arabia19 which 
corresponds to our findings. Wiwanitkit reported liver 
dysfunction in 35% of 191 patients. Hepatic 
encephalopathy was seen in 2.6% (5 cases) but no 
fatalities resulted.20 
A strong correlation has been reported 
between T cell activation and hepatic cellular 
infiltration in immunocompetent mice infected with 
dengue virus. It was noted that liver enzyme elevation 
correlated with T cell infiltration and activation.21 Fatty 
change, centrilobular necrosis and monocyte 
infiltration in the portal tract have been reported in 
humans.20 
The secreted form of dengue virus non-
structural protein NS 1 is also thought to be important. 
It is endocytosed by human phagocytes and 
accumulates in endosomes.22 it has been speculated 
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that this protein could play a role in liver damage and 
that the amount of NS1 accumulated would depend on 
the virulence of each particular strain and serotype 
infecting the liver cells.23 Receptors in hepatocytes 
have also been shown to have affinity for dengue virus 
serotype 1.12 
Paracetamol is usually administered in dengue 
infection to treat fever. However, paracetamol may 
increase in the risk of hepatic injury and severe liver 
damage has also been demonstrated.24 
In conclusion, Pakistan can now be counted 
among the countries harbouring dengue virus and its 
vector. The liver, though not the main target organ is 
affected in a large number of cases. Liver function tests 
are useful to evaluate the degree of liver damage and 
markers such as AST and ALT may be used as 
parameters to assess severity. They should be taken 
from the 3rd up to the 8th day of illness. If clinically 
indicated they can be repeated at least 3 weeks after 
discharge. Hepatitis serology is useful for patients 
with suspected hepatitis or persistent liver disease on 
follow-up. Routine hepatobiliary ultrasound in acute 
dengue infection is not recommended. On recovery, 
sonographic findings including ascites resolve 
spontaneously. 
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